kboreilly.com
FDA Refuses to Set Dosage, Duration Limits on Opioid Labels
After more than a year of research, public hearings, and consideration of nearly 3,000 comments filed by physician organizations, patients, and others, the U.S. Food and Drug Administration in Sept…